226 related articles for article (PubMed ID: 17604370)
21. Depolymerized products of lambda-carrageenan as a potent angiogenesis inhibitor.
Chen H; Yan X; Lin J; Wang F; Xu W
J Agric Food Chem; 2007 Aug; 55(17):6910-7. PubMed ID: 17661479
[TBL] [Abstract][Full Text] [Related]
22. Ghrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivo.
Conconi MT; Nico B; Guidolin D; Baiguera S; Spinazzi R; Rebuffat P; Malendowicz LK; Vacca A; Carraro G; Parnigotto PP; Nussdorfer GG; Ribatti D
Peptides; 2004 Dec; 25(12):2179-85. PubMed ID: 15572208
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo anti-angiogenesis effect of shallot (Allium ascalonicum): a heat-stable and flavonoid-rich fraction of shallot extract potently inhibits angiogenesis.
Seyfi P; Mostafaie A; Mansouri K; Arshadi D; Mohammadi-Motlagh HR; Kiani A
Toxicol In Vitro; 2010 Sep; 24(6):1655-61. PubMed ID: 20570718
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities.
An ZY; Yan YY; Peng D; Ou TM; Tan JH; Huang SL; An LK; Gu LQ; Huang ZS
Eur J Med Chem; 2010 Sep; 45(9):3895-903. PubMed ID: 20554355
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the antiangiogenic, anti-inflammatory, and antinociceptive activities of morin.
Jung HJ; Kim SJ; Song YS; Park EH; Lim CJ
Planta Med; 2010 Feb; 76(3):273-5. PubMed ID: 19774509
[TBL] [Abstract][Full Text] [Related]
26. Anti-angiogenic effect of an insertional fusion protein of human basic fibroblast growth factor and ribonuclease-1.
Hayashida T; Ueda M; Aiura K; Tada H; Onizuka M; Seno M; Yamada H; Kitajima M
Protein Eng Des Sel; 2005 Jul; 18(7):321-7. PubMed ID: 15980015
[TBL] [Abstract][Full Text] [Related]
27. The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling.
Park BC; Park SY; Lee JS; Mousa SA; Kim JT; Kwak MK; Kang KW; Lee ES; Choi HG; Yong CS; Kim JA
Vascul Pharmacol; 2009; 50(3-4):123-31. PubMed ID: 19068239
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
29. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348
[TBL] [Abstract][Full Text] [Related]
30. A novel integrin alpha5beta1 antagonistic peptide, A5-1, screened by Protein Chip system as a potent angiogenesis inhibitor.
Kim EY; Bang JY; Chang SI; Kang IC
Biochem Biophys Res Commun; 2008 Dec; 377(4):1288-93. PubMed ID: 18996355
[TBL] [Abstract][Full Text] [Related]
31. Anti-angiogenic effects of Shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis.
Tong Y; Zhang X; Zhao W; Zhang Y; Lang J; Shi Y; Tan W; Li M; Zhang Y; Tong L; Lu H; Lin L; Ding J
Eur J Pharmacol; 2004 Jun; 494(2-3):101-9. PubMed ID: 15212963
[TBL] [Abstract][Full Text] [Related]
32. [Anti-angiogenetic effect of arenobufagin in vitro and in vivo].
Liu JS; Zhang DM; Chen MF; Li MM; Luo QD; Kurihara H; Ye WC
Yao Xue Xue Bao; 2011 May; 46(5):527-33. PubMed ID: 21800539
[TBL] [Abstract][Full Text] [Related]
33. 5'-O-tritylated nucleoside derivatives: inhibition of thymidine phosphorylase and angiogenesis.
Liekens S; Bronckaers A; Hernández AI; Priego EM; Casanova E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
Mol Pharmacol; 2006 Aug; 70(2):501-9. PubMed ID: 16675660
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of angiogenesis by the poly(ADP-ribose) polymerase inhibitor PJ-34.
Pyriochou A; Olah G; Deitch EA; Szabó C; Papapetropoulos A
Int J Mol Med; 2008 Jul; 22(1):113-8. PubMed ID: 18575783
[TBL] [Abstract][Full Text] [Related]
35. Marine lysozyme from a marine bacterium that inhibits angiogenesis and tumor growth.
Ye J; Wang C; Chen X; Guo S; Sun M
Appl Microbiol Biotechnol; 2008 Jan; 77(6):1261-7. PubMed ID: 18043915
[TBL] [Abstract][Full Text] [Related]
36. Friend erythroleukemia cells induce angiogenesis in chick embryo chorioallantoic membrane and in human umbilical vein endothelial cells.
Pacini S; Punzi T; Gulisano M; Ruggiero M
Biol Res; 2008; 41(1):109-17. PubMed ID: 18769768
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil-activating protein-2- and interleukin-8-mediated angiogenesis.
Powell JA; Mousa SA
J Cell Biochem; 2007 Oct; 102(2):412-20. PubMed ID: 17352409
[TBL] [Abstract][Full Text] [Related]
38. Antiangiogenic activity of TZT-1027 (soblidotin) on chick chorioallantoic membrane and human umbilical vein endothelial cells.
Watanabe J; Endo Y; Shimada N; Natsume T; Sasaki T; Kobayashi M
In Vivo; 2007; 21(2):297-304. PubMed ID: 17436580
[TBL] [Abstract][Full Text] [Related]
39. 1-O-alkylglycerols reduce the stimulating effects of bFGF on endothelial cell proliferation in vitro.
Pédrono F; Saïag B; Moulinoux JP; Legrand AB
Cancer Lett; 2007 Jun; 251(2):317-22. PubMed ID: 17207571
[TBL] [Abstract][Full Text] [Related]
40. Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases.
Kim SA; Lee HJ; Ahn KS; Lee HJ; Lee EO; Ahn KS; Choi SH; Jung SJ; Kim JY; Baek N; Kim SH
Biol Pharm Bull; 2009 Jul; 32(7):1142-7. PubMed ID: 19571375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
